Quick Answer
iSpecimen Inc. reported Operating Income Loss of -$12.73 million for the year ending 2024.
- iSpecimen Inc. showed a decrease of -14.0% in Operating Income Loss from 2023 to 2024.
- This data is from iSpecimen Inc.'s annual report (Form 10-K), filed with the SEC on April 14, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2020 to 2024), iSpecimen Inc.'s Operating Income Loss has declined by 428.9%.
- Historical annual values: Fiscal year 2024: -$12.73 million | Fiscal year 2023: -$11.17 million | Fiscal year 2022: -$10.19 million | Fiscal year 2021: -$5.93 million | Fiscal year 2020: -$2.41 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: